Company Filing History:
Years Active: 2016-2025
Title: Mirna Mujacic: A Trailblazer in Genetic Engineering
Introduction
Mirna Mujacic, based in Seattle, Washington, is an innovative inventor recognized for her contributions to genetic engineering, particularly in the field of immunotherapy. With a remarkable portfolio that includes five patents, Mujacic is at the forefront of developing advanced techniques for producing genetically engineered cell compositions that hold the potential to revolutionize treatments for various diseases.
Latest Patents
Mujacic's latest patents focus on methods for producing genetically engineered cell compositions and related compositions. These methods involve generating engineered cells, which express recombinant receptors. Notably, her approach includes stimulating and engineering an input composition with a defined ratio of naïve-like CD4+ T cells to naïve-like CD8+ T cells. The processes she has developed enable the engineering of T cells with genetically engineered receptors, such as engineered T-cell receptors (TCRs) and chimeric antigen receptors (CARs), among other recombinant chimeric receptors. A significant aspect of her innovations is that they aim to produce T cell products that are more consistent, predictable, and exhibit lower toxicity compared to existing methods.
Career Highlights
Throughout her career, Mirna Mujacic has worked with renowned companies such as Amgen Inc. and Juno Therapeutics GmbH. Her experience in these leading organizations has allowed her to refine her skills and make substantial advancements in the field of genetic engineering. Mujacic's work continues to push the boundaries of what's possible in developing targeted cell therapies.
Collaborations
Mujacic has collaborated with notable individuals in her field, including Sandhya Pande and Ayu Rahardjo. These collaborations have provided opportunities for knowledge exchange and have played a crucial role in the successful development of her innovative methods and compositions.
Conclusion
In summary, Mirna Mujacic exemplifies the innovative spirit necessary in the realm of genetic engineering. Her patented methods for producing genetically engineered cell compositions are pioneering advancements that could significantly alter the landscape of therapeutic applications. With a strong background in reputable companies and valuable collaborations, Mujacic's contributions mark her as a leading figure in her field, paving the way for future breakthroughs in health and medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.